Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90

Molecular chaperones in cellular protein folding

1996 • 3,540 citations

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

2003 • 2,642 citations

HSP90 and the chaperoning of cancer

2005 • 2,352 citations

A new puffing pattern induced by temperature shock and DNP in drosophila

1962 • 1,969 citations

Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.

1994 • 1,426 citations

A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors

2003 • 1,356 citations

NF-κB as a Therapeutic Target in Multiple Myeloma

2002 • 906 citations

The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells.

1982 • 893 citations

Multiple myeloma: evolving genetic events and host interactions

2002 • 815 citations

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

2002 • 759 citations

Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90

2005 • 738 citations

Molecular chaperones in cellular protein folding

1994 • 497 citations

Mutagenicity of quinones: pathways of metabolic activation and detoxification.

1984 • 384 citations

DT-Diaphorase Expression and Tumor Cell Sensitivity to 17-Allylamino,17-demethoxygeldanamycin, an Inhibitor of Heat Shock Protein 90

1999 • 352 citations

The Hsp90 chaperone complex as a novel target for cancer therapy

2003 • 333 citations

Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3

2004 • 325 citations

Antimyeloma activity of heat shock protein-90 inhibition

2005 • 321 citations

NAD(P)H:Quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues

1993 • 268 citations

Therapeutic attack of hypoxic cells of solid tumors: presidential address.

1988 • 258 citations

Clinical toxicity of cryopreserved bone marrow graft infusion

1990 • 241 citations

NAD(P)H:Quinone Oxidoreductase 1 (NQO1, DT-Diaphorase), Functions and Pharmacogenetics

2004 • 239 citations

Clinical Development of 17-Allylamino, 17-Demethoxygeldanamycin

2003 • 226 citations

Requirement of Hsp90 activity for IκB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation

2004 • 214 citations

Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity

2004 • 208 citations

Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives

1995 • 198 citations

Crystal Structure and Molecular Modeling of 17-DMAG in Complex with Human Hsp90

2003 • 189 citations

Roles of molecular chaperones in protein degradation.

1996 • 186 citations

Design, Synthesis, and Biological Evaluation of Hydroquinone Derivatives of 17-Amino-17-demethoxygeldanamycin as Potent, Water-Soluble Inhibitors of Hsp90

2006 • 184 citations

Quinone Reductases Multitasking in the Metabolic World

2004 • 179 citations

Formation of 17-Allylamino-Demethoxygeldanamycin (17-AAG) Hydroquinone by NAD(P)H:Quinone Oxidoreductase 1: Role of 17-AAG Hydroquinone in Heat Shock Protein 90 Inhibition

2005 • 169 citations

Suspected anaphylactic reaction to Cremophor EL.

1980 • 167 citations

Clinical toxicity of cryopreserved circulating progenitor cells infusion.

1999 • 160 citations

Overview: Translating Hsp90 Biology into Hsp90 Drugs

2003 • 139 citations

erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships

1995 • 138 citations

Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations.

1998 • 132 citations

A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analogues

2006 • 112 citations

Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma

2006 • 65 citations

Possible role of DT-diaphorase in the bioactivation of antitumor quinones

1983 • 37 citations

Therapeutic implications of myeloma staging*

1989 • 25 citations